Form NPORT-P BlackRock Science & Tech For: Mar 31
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
- INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP Biologic™ for its Phase 3 Ready Flagship Indication
- MOBILITY GLOBAL INC. COMPLETES SEPARATION FROM S&P GLOBAL INC. AND BEGINS TRADING ON THE NEW YORK STOCK EXCHANGE AS A GLOBAL LEADER IN AUTOMOTIVE DATA & ANALYTICS
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
